Ticker brief

IOVA IOVANCE BIOTHERAPEUTICS INC

Consumer, Non-cyclical · Biotechnology

last close
$8.01
1 day
-3.0%
14 days
+14.8%
mkt cap
$1.9B
signals 14d
19
authors 14d
12
crowd 14d
+1.0σ
Options inteloptions-surface reads · latest available day per source
metricreadingcontext
IV — ATM 30d144%IV/HV 1.11× (as of 2026-07-31)
Skew — 25Δ RR 30d+0.25525Δ call IV − put IV
OI alarmquietlast alarm 2025-08-08 (z=2.4)
Sentiment — last 14 days
daily mean sentiment, 2026-08-17 → 2026-08-26 · now +0.20 (−1 bearish … +1 bullish)
Who spoke12
authorgradetrader scoresignalsmean sent
@PharmdcaC+0.826+0.59
@SandmanMarketsC-2.912+0.60
@StockPatternProC-0.322+0.50
@EllinRaulC+0.341+0.65
@zohmbasticC-1.381+0.40
@OptionsFlowBossC·1+0.55
@FintwitAiC+1.141+0.70
@kulturdeskenB-0.991+0.50
@AviNMashC-1.941+0.20
@ripster47C+0.241+0.45
@equityddC-2.031+0.35
@BioStocksC-3.021+0.40
Recent signals19of 19 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-08-26@Pharmdca+0.20Trimmed IOVA further to a 40% position ahead of lung-cancer data. — Reports a current risk-reduction action and remaining position size.-0.9%
2026-08-25@BioStocks+0.40TD Cowen raised its IOVA price target to $10.-5.1%
2026-08-24@equitydd+0.35Watchlist of high-growth stocks described as having good technical setups; ticker list is capped at six.-0.6%
2026-08-21@ripster47+0.45Endorses another trader's bullish callouts on IMMX and IOVA-3.4%
2026-08-21@Pharmdca+0.50Reports trimming IMMX above $13.4 after a run toward 52-week highs and notes IOVA's fresh high.-3.4%
2026-08-20@AviNMash+0.20Calls IOVA 'kinda fun,' expressing mild positive interest without a thesis.-10.9%
2026-08-20@kulturdesken+0.50Labels IOVA an episodic-pivot setup, with the chart needed for details.-10.9%
2026-08-20@Pharmdca+0.80Recaps a prior bullish call after the stock gained more than 300%.-10.9%
2026-08-20@FintwitAi+0.70Promotes a prior AI flag after IOVA gained 120% from 4.10.-10.9%
2026-08-20@Pharmdca+0.40Trim IOVA near $9 while holding the core position. — States a current partial trim near $9 while retaining a bullish core holding.-10.9%
2026-08-20@Pharmdca+0.80Explicitly discloses a long and supports it with breakout, earnings, margin, cost, and catalyst evidence.-10.9%
2026-08-20@StockPatternPro+0.45Reports IOVA moving sharply higher in real time.-10.9%
2026-08-20@OptionsFlowBoss+0.55Lists unusual bullish options-volume multiples for six names.-10.9%
2026-08-20@StockPatternPro+0.55Author endorses a chart-based $15 target for IOVA.-10.9%
2026-08-19@Pharmdca+0.85Discloses a long position and bullish turnaround thesis ahead of lung-cancer data.+0.3%
2026-08-19@SandmanMarkets+0.50Reports IOVA crossing a 100% gain threshold after earlier analysis.+0.3%
2026-08-18@zohmbastic+0.40Mizuho raises Iovance's target to $11 from $10 and maintains Outperform.+13.9%
2026-08-17@SandmanMarkets+0.70Reports IOVA up 93% from prior analysis and asks whether it will become a 100% runner+12.8%
2026-08-17@EllinRaul+0.65Celebrates IOVA having already reached $7 and implies followers should have caught the move.+12.8%

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.